+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ophthalmic Devices Market Analysis by Product (Optical Coherence Tomography, Ophthalmic Ultrasound), by Application (Cataract, Glaucoma), by End Use (Hospitals and Eye Clinics) and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 120 Pages
  • April 2022
  • Region: Global
  • Grand View Research
  • ID: 5595807
The global ophthalmic devices market size is expected to reach USD 9.8 billion by 2030. The market is expected to expand at a CAGR of 5.0% from 2022 to 2030.



The rising geriatric population is presumed to propel the need for ophthalmic devices as this age group is more prone to the development of chronic eye disorders. According to the National Institute on Aging (NIA), the geriatric population would be about 72 million individuals by 2030. The rising prevalence of eye disorders such as macular degeneration, cataract, diabetic retinopathy, and glaucoma is also boosting the growth of ophthalmic devices.

As per WHO, glaucoma accounts for 4.5 million cases of blindness globally. In the United States, glaucoma is termed as the 'Silent Thief of Sight' which is the second-leading cause of blindness. The market growth can also be attributed to technological advancements such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform

Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision in spite of the proper treatment as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, the rising demand for minimally invasive and complication-free operative surgeries is expected to upsurge the demand for ophthalmic devices. Due to the Covid 19 pandemic, the majority of the population's screen time has increased, resulting in a variety of eye issues, is projected to boost the market's growth. However, reduction in elective surgeries, closure of eye clinics, and the fear of viral spread, led to the reduction in the adoption of ophthalmic devices, declining the market growth.

Ophthalmic Devices Market Report Highlights

  • The optical coherence tomography (OCT) scanners segment dominated the product segment of the overall market in terms of revenue share at over 23% in 2021, owing to its wide range of applications.
  • The Ophthalmoscopes segment is expected to witness significant growth during the forecast period, owing to technological advancements.
  • Based on application, the cataract segment accounted for the largest revenue share in 2021 and is further expected to continue its dominance over the forecast period, owing to the increasing number of patients suffering from cataracts and the high adoption of ophthalmic devices for cataract surgeries.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Ophthalmic Devices Market

What is the estimated value of the Global Ophthalmic Devices Market?

The Global Ophthalmic Devices Market was estimated to be valued at $6.6 Billion in 2022.

What is the growth rate of the Global Ophthalmic Devices Market?

The growth rate of the Global Ophthalmic Devices Market is 5.0%, with an estimated value of $9.8 Billion by 2030.

What is the forecasted size of the Global Ophthalmic Devices Market?

The Global Ophthalmic Devices Market is estimated to be worth $9.8 Billion by 2030.

Who are the key companies in the Global Ophthalmic Devices Market?

Key companies in the Global Ophthalmic Devices Market include Johnson & Johnson Vision Care, Alcon Vision LLC, Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Essilor International S.A, Ziemer Ophthalmic Systems Ltd, Nidek Co. Ltd., Topcon Corporation and Streit Group.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Ophthalmic Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Rising prevalence of eye disease
3.4.1.2. Technological advancements in ophthalmic surgical and diagnostic instruments
3.4.1.3. Government initiatives for increasing awareness related to visual impairment
3.4.2. Market Restraint Analysis
3.4.2.1. Lack of trained ophthalmologist in developing nations
3.4.2.2. High cost of devices in developing nations
3.5. Ophthalmic Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat of New Entrant
3.5.1.5. Competitive Rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Economic Landscape
3.5.2.6. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Ophthalmic Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Optical Coherence Tomography (OCT)
4.1.2. Fundus camera
4.1.3. Perimeters/Visual Field Analyzers
4.1.4. Autorefractors and Keratometers
4.1.5. Ophthalmic Ultrasound Imaging Systems
4.1.5.1. Ophthalmic A-Scan Ultrasound
4.1.5.2. Ophthalmic B-Scan Ultrasound
4.1.5.3. Ophthalmic Ultrasound Biomicroscopes
4.1.5.4. Ophthalmic Pachymeters
4.1.6. Tonometers
4.1.7. Slit lamps
4.1.8. Phoropters
4.1.9. Wavefront Aberrometers
4.1.10. Optical Biometry Systems
4.1.11. Ophthalmoscopes
4.1.12. Lensometers
4.1.13. Corneal Topography Systems
4.1.14. Specular Microscopes
4.1.15. Retinoscopes
4.2. Product Market Share, 2017 & 2030
4.3. Segment Dashboard
4.4. Global Ophthalmic Devices Market Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
4.5.1. Optical Coherence Tomography (OCT)
4.5.1.1. OCT market estimates and forecast 2017 to 2030, (USD Million)
4.5.2. Fundus camera
4.5.2.1. Fundus camera market estimates and forecast 2017 to 2030, (USD Million)
4.5.3. Perimeters/visual field analyzers
4.5.3.1. Perimeters/visual field analyzers market estimates and forecast 2017 to 2030, (USD Million)
4.5.4. Autorefractors and keratometers
4.5.4.1. Autorefractors and keratometers market estimates and forecast 2017 to 2030, (USD Million)
4.5.5. Ophthalmic Ultrasound Imaging Systems
4.5.5.1. Ophthalmic Ultrasound Imaging Systems market estimates and forecast 2017 to 2030, (USD Million)
4.5.5.2. Ophthalmic A Scan Ultrasound market estimates and forecast 2017 to 2030, (USD Million)
4.5.5.3. Ophthalmic B Scan Ultrasound market estimates and forecast 2017 to 2030, (USD Million)
4.5.5.4. Ophthalmic Ultrasound Biomicroscopes market estimates and forecast 2017 to 2030, (USD Million)
4.5.5.5. Ophthalmic Ultrasound Pachymeters market estimates and forecast 2017 to 2030, (USD Million)
4.5.6. Tonometers
4.5.6.1. Tonometers market estimates and forecast 2017 to 2030, (USD Million)
4.5.7. Slit lamps
4.5.7.1. Slit lamps market estimates and forecast 2017 to 2030, (USD Million)
4.5.8. Phoropters
4.5.8.1. Phoropters market estimates and forecast 2017 to 2030, (USD Million)
4.5.9. Wavefront Aberrometers
4.5.9.1. Wavefront Aberrometers market estimates and forecast 2017 to 2030, (USD Million)
4.5.10. Optical Biometry Systems
4.5.10.1. Optical Biometry Systems market estimates and forecast 2017 to 2030, (USD Million)
4.5.11. Ophthalmoscopes
4.5.11.1. Ophthalmoscopes market estimates and forecast 2017 to 2030, (USD Million)
4.5.12. Lensometers
4.5.12.1. Lensometers market estimates and forecast 2017 to 2030, (USD Million)
4.5.13. Corneal Topography Systems
4.5.13.1. Corneal Topography Systems market estimates and forecast 2017 to 2030, (USD Million)
4.5.14. Specular Microscopes
4.5.14.1. Specular Microscopes market estimates and forecast 2017 to 2030, (USD Million)
4.5.15. Retinoscopes
4.5.15.1. Retinoscopes market estimates and forecast 2017 to 2030, (USD Million)
Chapter 5. Ophthalmic Devices Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Cataract
5.1.2. Vitreo retinal disorders
5.1.3. Glaucoma
5.1.4. Refractor Disorders
5.2. Application Market Share, 2017 & 2030
5.3. Segment Dashboard
5.4. Global Ophthalmic Devices Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
5.5.1. Cataract
5.5.1.1. Cataract estimates and forecast 2017 to 2030, (USD Million)
5.5.2. Vitero retinal disorders
5.5.2.1. Vitero retinal disorders market estimates and forecast 2017 to 2030, (USD Million)
5.5.3. Glaucoma
5.5.3.1. Glaucoma market estimates and forecast 2017 to 2030, (USD Million)
5.5.4. Refractor Disorders
5.5.4.1. Refractor disorders market estimates and forecast 2017 to 2030, (USD Million)
Chapter 6. Ophthalmic Devices Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals and Eye Clinic
6.1.2. Academic and Research Laboratory
6.1.3. Others
6.2. End-use Market Share, 2017 & 2030
6.3. Segment Dashboard
6.4. Global Ophthalmic Devices Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
6.5.1. Hospitals and Eye Clinic
6.5.1.1. Hospitals and Eye Clinics estimates and forecast 2017 to 2030, (USD Million)
6.5.2. Academic and Research Laboratory
6.5.2.1. Academic and Research Laboratory market estimates and forecast 2017 to 2030, (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2017 to 2030, (USD Million)
Chapter 7. Ophthalmic Devices Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2017 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2017
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2017 to 2030:
7.7. North America
7.7.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.7.3. Canada
7.7.3.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.2. Germany
7.8.2.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.3. France
7.8.3.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.4. Italy
7.8.4.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.5. Russia
7.8.5.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.6. Netherlands
7.8.6.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.7. Switzerland
7.8.7.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.8. Ireland
7.8.8.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.9. Poland
7.8.9.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.8.10. Sweden
7.8.10.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast 2017 - 2030 (Volume, Thousand)
7.9.2. China
7.9.2.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.3. India
7.9.3.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.4. Indonesia
7.9.4.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.5. Thailand
7.9.5.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.6. Australia
7.9.6.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.7. South Korea
7.9.7.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.8. Malaysia
7.9.8.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.9. Philippines
7.9.9.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.9.10. Singapore
7.9.10.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11.3. Turkey
7.11.3.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11.4. Iran
7.11.4.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11.5. UAE
7.11.5.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
7.11.6. Israel
7.11.6.1. Market estimates and forecast 2017 - 2030 (Value & Volume)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Johnson & Johnson Vision Care
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Modality benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Alcon Vision LLC
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Modality benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Carl Zeiss Meditec AG
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Modality benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Bausch & Lomb Incorporated
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Modality benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Essilor International S.A
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Modality benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Ziemer Ophthalmic Systems Ltd
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Modality benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Nidek Co. Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Modality benchmarking
8.3.10.4. Strategic initiatives
8.3.11. TOPCON CORPORATION
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Modality benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Haag-Streit Group
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Modality benchmarking
8.3.12.4. Strategic initiatives

Companies Mentioned

  • Johnson & Johnson Vision Care
  • Alcon Vision LLC
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated
  • Essilor International S.A
  • Ziemer Ophthalmic Systems Ltd
  • Nidek Co. Ltd.
  • Topcon Corporation
  • Haag-Streit Group

Methodology

Loading
LOADING...